Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures.
A trial in the UK to study the effect on mortality from breast cancer of invitation for annual mammography from the age of 40-41, has randomised a total of 160 921 women in the ratio 1 : 2 to the intervention and control arms. All breast cancers diagnosed in the two arms have been identified, and the histology reviewed. This paper presents the results of an interim analysis using surrogate outcome measures to compare predicted breast cancer mortality in the two arms based on 1287 cases diagnosed to 31.12.1999. Due to earlier diagnosis, there is currently an 8% excess of invasive breast cancers in the intervention arm. The ratio of predicted deaths at 10 years in the intervention arm relative to the control arm, adjusted for this excess diagnosis, ranges from 0.89 (95% confidence interval (CI) 0.78-1.01) to 0.90 (95% CI 0.80-1.01). Screening from age 40 may result in a lower reduction in breast cancer mortality than that observed in other trials including women below age 50. This analysis based on surrogate outcome measures suggests that a reduction in breast cancer mortality may be observed in this trial. However, a number of assumptions have been necessary and firm conclusions must await the analysis of observed mortality from breast cancer.
Moss
S
S
Cancer Screening Evaluation Unit, Institute of Cancer Research, Brookes Lawley Building, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK. sue.moss@icr.ac.uk
Waller
M
M
Anderson
T J
TJ
Cuckle
H
H
D000328:Adult; D001943:Breast Neoplasms / Q000401:mortality* / Q000473:pathology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008327:Mammography; D008875:Middle Aged; D018401:Sample Size; D006113:United Kingdom / Q000453:epidemiology
J Natl Cancer Inst Monogr. 1997;(22):87-92
9709282
Cancer. 1997 Dec 1;80(11):2091-9
9392331
Hum Pathol. 2002 Mar;33(3):365-71
11979379
J Natl Cancer Inst. 1995 Aug 16;87(16):1217-23
7563167
Br J Cancer. 2005 Mar 14;92(5):949-54
15726102
Int J Epidemiol. 1991 Sep;20(3):642-50
1955248
Br J Cancer. 1987 Oct;56(4):489-92
3689666
Eur J Cancer. 2002 Jul;38(11):1458-64
12110490
J Med Screen. 1999;6(3):144-8
10572845
J Med Screen. 1995;2(2):94-8
7497163
Cancer. 1995 May 15;75(10):2507-17
7736395
Br J Cancer. 2000 Aug;83(4):487-92
10945496
Cancer. 1997 Jan 1;79(1):1-2
8988719
Int J Epidemiol. 1996 Dec;25(6):1139-45
9027517
J Med Screen. 2004;11(1):23-7
15006110